Phase A — Understand the business
Lens 1 · Company Overview
Redwire Corporation (NYSE: RDW, CIK 0001819810, HQ Jacksonville FL, incorporated Delaware) is a space-infrastructure-and-defense-technology company assembled by private-equity firm AE Industrial Partners (AEI) via a 2020 SPAC and a string of bolt-on acquisitions. As of December 2025 it reports in two segments: Space and Defense Tech.
What it actually sells:
- Space segment — next-gen spacecraft and platforms (the SabreSat "orbital drone" for US VLEO and the Phantom VLEO platform in Europe), large space infrastructure, critical avionics, Roll-Out Solar Arrays (ROSA), deployable structures, digital-engineering services, and a genuinely differentiated in-space biomanufacturing / microgravity franchise (the PIL-BOX pharmaceutical platform, run under NASA ISS IDIQ contracts). Customers are civil (NASA, ESA), national-security (DoD, DARPA, intelligence), and commercial space.
- Defense Tech segment — created by the June 2025 acquisition of Edge Autonomy: combat-proven uncrewed airborne systems (UAS/drones), optical sensors, and RF payloads for ISR. Flagship platforms are the Penguin (long-endurance, sub-$20K, used as a quasi-expendable asset, delivered directly to Ukraine's armed forces since 2022) and the VXE30 Stalker (up to 25-hr endurance, 180 km LOS range; 200+ delivered to the USMC under Navy PMA-263), plus the Lanner VTOL co-developed with Safran.
Contract structure / payment terms. Predominantly government and prime-contractor contracts: firm-fixed-price (FFP), cost-plus-fixed-fee (CPFF), and time-and-materials, with revenue recognized over time on the cost-to-cost (EAC) method for most Space work. This EAC accounting is the single most important thing to understand about the income statement — see Lens 5/10. Customer concentration is high: the two largest customers were ~19% and ~20% of FY2025 revenue.
The plain-terms model: Redwire is a dual-use government contractor — it sells picks-and-shovels into two secular bull markets (the orbital economy and attritable/ISR drones) and is rolled up by a defense-focused PE sponsor that still controls it.
Lens 2 · Supply Chain
Map: raw materials & components → Redwire / Edge Autonomy manufacturing → prime contractors / governments → end mission.
- Upstream inputs. "Certain aspects of our manufacturing activities require relatively scarce raw materials; occasionally, we have experienced difficulty in our ability to procure raw materials, components, sub-assemblies, and other supplies". Redwire uses its own production plus a base of third-party suppliers and subcontractors. Named manufacturing footprint: US plants (Penguin now built in California; Jacksonville/Huntsville space facilities — a new Huntsville AL lease created $12.3M of future obligations ) and European factories (Space Europe in Belgium/Luxembourg, Edge Autonomy's European UAS factory).
- Midstream (Redwire itself). Two value chains: (1) space hardware (spacecraft, ROSA, IBDM docking mechanisms, PIL-BOX); (2) UAS airframes + payloads (Penguin, VXE30 Stalker, Lanner).
- Named downstream stakeholders / customers. NASA (ISS biomanufacturing IDIQ, ~$25M + $4M follow-ons), ESA (via prime Thales Alenia Space — IBDM docking mechanisms for the lunar Gateway I-Hab; ROSA follow-ons; Skimsat where Redwire is prime on the Phantom platform), DARPA (Otter/SabreSat VLEO, $44M Phase 2, Nov 2025), the US Navy/Marine Corps (PMA-263 Stalker), and the Armed Forces of Ukraine (Penguin). Partner/co-developer: Safran (Lanner VTOL).
- Chokepoints / single-source. International backlog of $193.1M sits in Europe and is FX-exposed (euro). Tariff and trade-action risk is explicitly flagged because Edge's European factory supplies non-US customers. The Ukraine demand channel is geopolitically contingent (war-duration-dependent). No single supplier is disclosed as a make-or-break dependency, but scarce-materials procurement is a named operational risk.
Lens 3 · Competitive Advantages (moats)
Redwire's moats are real but narrow and not yet margin-protective:
- Flight heritage / qualification barriers (Space). ROSA, deployable structures, and the IBDM are flight-proven and spec'd into multi-year programs (Gateway, commercial LEO stations). In government space, qualification + incumbency is a genuine switching-cost moat — but it co-exists with brutal fixed-price EAC risk (Lens 5).
- Combat-proven status (Defense Tech). The Penguin and VXE30 Stalker are "combat-proven" in Ukraine and fielded at scale by the USMC — a credential competitors cannot manufacture quickly. Attritable, low-cost ($<20K) drones with 25-hr endurance hit the exact sweet spot the 2024-26 drone-warfare doctrine demands.
- VLEO franchise. Being DARPA's prime on air-breathing-propulsion VLEO (SabreSat/Otter) plus the European Phantom/Skimsat work gives Redwire a defensible early lead in a nascent orbital regime.
- Differentiated IP in microgravity manufacturing. The PIL-BOX pharma-crystallization platform is a rare commercial in-space-manufacturing revenue line.
Bargaining power: weak. Customer concentration (~39% top two) and a government/prime customer base mean Redwire is mostly a price-taker; the 10-K concedes competition from "established defense contractors... many of which are larger than us and have greater technical, manufacturing and financial resources," and that low-cost commercial drone makers keep improving. The IP portfolio is held to be valuable in aggregate but the company states no single patent is material. Net: the moat is qualification + combat-credential, not pricing power — which is exactly why gross margin is thin.
Lens 4 · Segments
All segment figures ``. (in $000s)
| Segment | FY2025 rev | FY2024 rev | FY2023 rev | FY25 op inc (loss) | FY25 op margin |
|---|
| Space | 209,817 | 255,336 | 194,000 | (49,155) | (23)% |
| Defense Tech | 125,564 | 48,765 | 49,800 | (93,553) | (75)% |
| Total (segment) | 335,381 | 304,101 | 243,800 | (142,708) | — |
| Unallocated (corp + transaction) | — | — | — | (86,969) | — |
| Total consolidated op loss | — | — | — | (229,677) | — |
Trend & cause:
- Space decelerated and went loss-making — revenue −18% YoY ($255.3M→$209.8M), op margin 6%→(23)%. Drivers: $28.1M of net unfavorable EAC adjustments (vs $15.3M prior year) + production-cycle timing on large power-generation contracts + a $34.4M impairment of the Space Europe reporting unit. This is the soft underbelly: the legacy space business is shrinking and bleeding on fixed-price overruns.
- Defense Tech exploded — revenue +157% YoY, almost entirely $107.1M from Edge Autonomy (a partial-year, ~6.5-month contribution post-June close). But the segment posted a −75% op margin / −$93.6M op loss, driven by $44.4M of Edge Incentive Unit comp, a $13.6M non-cash inventory step-up, $20.2M extra D&A, and $25.8M of unfavorable EACs. Strip the non-cash/non-recurring purchase-accounting noise and Defense Tech's underlying economics are far better than the GAAP line — but the reported number is ugly.
- Geography: International (mostly European) backlog jumped to $193.1M (from $70.5M) as Edge's European UAS franchise consolidated. Consolidated gross margin collapsed to 5.2% FY25 (gross profit $17.3M on $335.4M) from 14.6% FY24 — almost entirely the EAC + purchase-accounting drag.
Phase B — Measure performance
Lens 5 · Earnings Result (latest print: Q1 2026, filed 2026-05-07)
GAAP income statement, Q1 2026 vs Q1 2025 `` (in $000s):
| Q1 2026 | Q1 2025 |
|---|
| Revenue | 96,972 | 61,395 |
| Cost of sales | 71,164 | 52,354 |
| Gross profit | 25,808 (26.6%) | 9,041 (14.7%) |
| SG&A | 82,887 | 18,746 |
| R&D | 12,582 | 813 |
| Operating loss | (69,701) | (14,317) |
| Net loss | (76,502) | (2,948) |
| Net loss to common | (78,014) | (6,479) |
| EPS (basic & diluted) | (0.40) | (0.09) |
| Wtd-avg shares | 193,672,276 | 71,192,148 |
Read of the print:
- Revenue +58% YoY to $97.0M — the first quarter with a full Edge Autonomy contribution; Space $52.7M, Defense Tech $44.3M. Management reaffirmed FY2026 guidance of $450–500M (~41.6% YoY growth at midpoint).
- Gross margin recovered to 27% from 15% — Edge's higher-margin mix + fewer EAC hits. This is the most encouraging data point in the whole file.
- But net loss widened to −$76.5M. The damage is >$42.5M of accelerated, non-cash, non-dilutive equity-based compensation tied to Edge Autonomy vesting inside the $82.9M SG&A line; management flags ~$44M of the loss as non-recurring. Adjusted EBITDA was −$9.2M — still negative but a sharp improvement off the FY2025 −$50.3M run-rate.
- Balance-sheet flags: interest expense actually fell ($2.5M vs $3.6M) after the February 2026 debt refinance; a $2.5M loss on debt extinguishment ran through the quarter.
- Market reaction: the print's record backlog ($498.1M) and margin recovery were overshadowed by the dilution narrative — the stock has been driven far more by the $500M ATM overhang than by operating results (Lens 8).
- Unusual vs own history: the share count went from 71.2M (Q1'25) to 193.7M (Q1'26) weighted-average — a ~2.7x increase. The denominator is moving faster than the numerator.
Book-to-bill 1.92x in Q1 2026; record contracted backlog $498.1M — up from the $411.2M at year-end. Bookings momentum is unambiguously strong.
Lens 6 · Earnings Calls (sentiment trend)
No transcripts on the shelf (transcripts=0); this lens is ``. Across the FY2025 → Q1 2026 calls the management narrative shifted on a clear arc:
- 2025 (the "stumble"): tone defensive — government-shutdown order delays, EAC overruns in Space, integration cost, "growth over profits." FY2025 came in at the low end ($335M vs a $320–340M guide).
- Q1 2026: tone pivoted to confidence on scale and backlog — "record contract backlog," "significant gross margin improvement," reaffirmed guide, and repeated emphasis that the headline loss is non-cash Edge vesting, not operating deterioration.
- Recurring phrases: "Golden Dome," "VLEO leadership," "combat-proven," "book-to-bill," "differentiated products." Stopped saying: the standalone-space-pure-play framing — Redwire now sells itself as a dual-use space + defense platform. The consistent through-line management wants investors to hold: the operating business is inflecting; the GAAP losses are acquisition/comp artifacts that roll off.
Lens 7 · Comps
Peer set: space-infrastructure + new-space + dual-use names. Multiples are `` with date or marked n/a. None fabricated. Note: every space name here is loss-making or thin-margin, so P/E and ROE are largely meaningless — the market prices these on EV/forward-sales.
| Company | Ticker | Mkt cap | FY26E revenue | P/S (trailing) | EV/fwd sales | P/E | 5-yr avg ROE |
|---|
| Redwire | RDW | ~$2.5B | $450–500M guide | ~13.7x / ~7x — see conflict | ~5.3x | n/m (loss) | n/m (loss) |
| Rocket Lab | RKLB | ~$38.8–58.1B | n/a (Q1 rev $200M, +64%) | n/a | n/a | n/m | n/m |
| Intuitive Machines | LUNR | n/a | $900M–1.0B guide | ~14x sales | n/a | n/m | n/m |
| Voyager Technologies | VOYG | n/a | $225–255M guide | n/a | n/a | n/m | n/m |
| Firefly Aerospace | FLY | n/a | n/a (record Q rev) | n/a | n/a | n/m | n/m |
| AST SpaceMobile | ASTS | n/a | n/a | n/a | n/a | n/m | n/m |
Lens 8 · Stock-Price Catalysts (what moves RDW >5%)
`` throughout. The pattern is unusually clean and it is the most important behavioral fact about this name: RDW trades on capital-structure events and sector sentiment, not on its own fundamentals.
- Dilution events = the dominant down-catalyst. RDW fell as much as 17.3% to a $15.35 session low on launching a $500M ATM offering (after withdrawing a prior $350M plan). Shareholders were diluted ~94–100%+ over 12 months.
- Sector / SpaceX-IPO mania = the dominant up-catalyst. Space names (RDW, RKLB, LUNR, ASTS) spiked into SpaceX's June 12, 2026 IPO, then sold off when the rumored valuation reportedly slipped below $2T. RDW gained ~57% over a 3-month window inside this.
- Contract awards = sharp but short-lived pops. The $44M DARPA Otter/SabreSat VLEO Phase 2 award (Nov 2025) and the "Golden Dome" missile-defense narrative ($542B TAM / $25B initial) move the stock on headlines.
- Earnings. FY2025's low-end print + 55% 2025 drawdown; Q1 2026's record backlog. Reactions are real but secondary to dilution/sector flow.
- Short interest ~22.4% of float (36.9M shares) — high; makes the stock a two-sided squeeze/overhang vehicle. 52-week range $4.87–$26.64 — a 5.5x peak-to-trough; this is a high-beta sentiment instrument.
Phase C — Judge people & books
Lens 9 · Management
- Peter Cannito — Chairman & CEO since June 2020. Background ``: an AEI Operating Partner since 2019 (i.e. the sponsor's own man), former CEO of Polaris Alpha (Oct 2016–Dec 2018, a DoD/IC high-tech solutions firm sold to Parsons), former CEO/COO of EOIR Technologies, ex-Booz Allen, USMC officer; finance degree (Delaware) + MBA (Maryland). Archetype: a PE-installed defense roll-up operator, not a founder-engineer. Track record is M&A-and-integration, which is exactly Redwire's playbook — and exactly its risk.
- Tenure & skin in the game. Cannito's incentives run through the AEI relationship; this is a sponsor-controlled company. AEI beneficially owns ~48.7% of common + as-converted preferred and appoints a majority of the board. Insider-transaction CSV not on shelf —
n/a on precise officer ownership.
- Capital-allocation history. Aggressive M&A roll-up (Edge Autonomy ~$1.0B in 2025; Hera Systems 2024; earlier bolt-ons) funded by a mix of stock, preferred, and high-cost debt. ROE/ROIC are negative throughout (cumulative net losses since inception). The defining capital-allocation act of FY2025 is the massive equity issuance ($518.4M of stock/warrant proceeds) used to fund the Edge cash consideration and repay debt — value-accretive if Edge's growth compounds, dilutive-and-painful if it doesn't.
- Red flags. (1) Related-party acquisition: Edge Autonomy was bought from Edge Ultimate Holdings, an affiliate of AEI — i.e. AEI sold its own portfolio company to the AEI-controlled public company, financed partly by a $100M Seller Note to an AEI affiliate at 15%→18% interest. (2) AEI can force a company-sale process after the 7th anniversary of the preferred. (3) Two securities/derivative lawsuits named Cannito personally over alleged misleading statements re internal-control weaknesses (Lens 10). (4) $59M of equity-based comp in FY2025 including $44.4M of Edge Incentive Units — heavy.
- Founder vs professional manager: firmly professional/sponsor-driven. Implication for this stage: execution-and-integration competence is plausibly high, but minority common holders are riding behind AEI's interests, and the float has been the funding source.
Lens 10 · Forensic Red Flags
Forensic lens. The accounting is aggressive-but-disclosed, not fraudulent — KPMG (Houston, Firm ID 185) issued a clean opinion with an ICFR attestation and no going-concern qualification. The risks are concentrated in five places, all `` unless noted:
- EAC / percentage-of-completion revenue (the #1 watch item). Most Space revenue is recognized on the cost-to-cost method, which depends on management's estimate of total contract cost. FY2025 absorbed $28.1M (Space) + $25.8M (Defense Tech) of net unfavorable EAC adjustments — i.e. prior-period revenue was effectively over-recognized and reversed. Serial unfavorable EAC swings are the classic forensic flag for fixed-price hardware contractors; it directly caused the 5.2% gross margin.
- Goodwill & intangibles concentration. Post-Edge, goodwill is $779.1M and intangibles $336.2M against $1,449.1M total assets — ~77% of assets are acquisition-derived intangibles. FY2025 already took a $34.7M impairment (Space Europe goodwill to zero + tangible/intangible write-downs). The $721.3M of Edge goodwill is the next impairment candidate if defense growth disappoints — management explicitly names this risk.
- Cash flow vs earnings divergence. Operating cash flow was −$177.3M FY25 (vs a −$226.6M net loss) — the gap is the $101.2M of non-cash add-backs (SBC, D&A, impairment, inventory step-up). The tell is the trend: operating burn went from −$17.3M (FY24) to −$177.3M (FY25), 10x worse, $74M of it working-capital deterioration (deferred revenue down $34M). Adjusted EBITDA −$50.3M FY25 masks how much real cash left the building.
- Stock-based comp flattering non-GAAP / diluting common. $59.0M SBC FY2025 and $42.5M accelerated Edge vesting in Q1 2026 are added back to adjusted EBITDA but are real economic transfers to insiders and real dilution.
- Preferred-stock & warrant complexity. Series A Convertible Preferred (PIK at 15%, cash at 13%, $3.05 conversion, $118.4M liquidation preference, mandatory-convert thresholds) plus historically large private-warrant mark-to-market swings (a $52.0M loss in FY24 flipped to a $16.1M gain in FY25 through "other income/expense" — a $68M non-operating swing that distorts year-over-year net loss comparisons). The $45.8M of preferred dividends widen the loss-to-common well beyond the operating loss.
Regulatory findings (required sub-section):
- SEC enforcement: "No LR found" and "No AAER found" for Redwire 2021-2026 per EDGAR EFTS.
- Securities/derivative litigation (10-K Item 3 / Note M, quoted ``): Lemen v. Redwire Corp. (M.D. Fla., filed Dec 17, 2021) — putative securities class action naming the Company, CEO Peter Cannito, and former CFO William Read, alleging misleading statements / undisclosed material weaknesses in financial-reporting internal controls (2021-2022); settled for $8.0M (paid into escrow 2025, dismissed with prejudice Aug 18, 2025; ~$1.1M insurance recovery). Yingling v. Cannito et al. (D. Del., filed May 25, 2022) — related derivative suit, same internal-control allegations + overpaid performance comp; settled in principle Aug 14, 2025 via corporate-governance reforms + $0.9M fees. Read: Redwire has a documented history of financial-reporting internal-control weakness allegations — a material context for the EAC-accounting risk above, even though both matters are resolved without admission.
- Non-SEC enforcement (web search
"Redwire" (FTC OR DOJ OR FDA OR CFPB OR settlement OR fine OR penalty) enforcement): no material agency enforcement actions surfaced as of 2026-06-23 ``.
- Net: No SEC accounting-fraud enforcement; one settled securities class action ($8.0M) and one settled derivative suit, both centered on early-life (2021-22) internal-control disclosure. Verified via SEC EDGAR EFTS (LR, AAER), 10-K Item 3, and web search as of 2026-06-23.
Phase D — Project & stress-test
Lens 11 · Forward Projection (FY2026 / FY2027 / FY2028)
RDW is a loss-making, non-GAAP-EPS-negative name, so the meaningful projection is revenue, gross margin trajectory, and the path to positive adjusted EBITDA / free-cash-flow breakeven — not a clean EPS line. Built bottom-up from FY2025 actuals + the Q1 2026 print + reaffirmed guidance. All outputs `` with inputs labeled.
Base inputs:
- FY2025 revenue $335.4M; FY2026 management guide $450–500M (midpoint $475M, +41.6%); Q1 2026 already $97.0M with 1.92x book-to-bill and $498.1M backlog.
- Gross margin: 5.2% FY25 → ~27% Q1'26; normalize to ~22–25% FY26 as EAC noise and inventory step-up roll off.
- Adjusted EBITDA: −$50.3M FY25 → −$9.2M Q1'26; the inflection lever is operating leverage on the higher-margin Edge revenue once accelerated SBC rolls off.
| Scenario | FY26 rev | FY27 rev | FY28 rev | Adj. EBITDA path | Note |
|---|
| Bull | $500M | $675M | $875M | breakeven late-26, ~+10% EBITDA margin FY28 | Golden Dome + VLEO + Edge scale; ROW defense demand sustained |
| Base | $475M | $585M | $700M | adj. EBITDA breakeven ~mid/late-2027 | guide midpoint, book-to-bill normalizes to ~1.2x, margin to ~24% |
| Bear | $440M | $470M | $490M | adj. EBITDA stays negative through FY28 | Ukraine demand fades, EAC overruns recur, Space stays soft, more dilution |
``. EPS remains negative in base/bear through FY27 given ongoing SBC + preferred dividends + a 190M+ (and rising) share count; a clean GAAP-EPS-positive year is not in the visible window.
Forecast NOT logged — per --watchlist rules I do not run forecast.ts create in the breadth loop, and I have not committed to a base case at a level worth Brier-scoring. The scoreable binary if promoted to /thesis would be: "RDW reports positive adjusted EBITDA in any quarter on/before Q4 2027."
Lens 12 · Bull vs Bear
Bull case. Redwire is a rare dual-use pure-play on two secular bull markets at once — the orbital economy (VLEO leadership via SabreSat/Phantom, in-space manufacturing, Gateway/LEO-station infrastructure) and attritable/ISR drones (combat-proven Penguin + Stalker at the exact doctrinal sweet spot). Backlog is at a record $498.1M with a 1.92x book-to-bill, revenue is compounding ~40%+, gross margin already snapped back to 27%, and the company sits in front of two enormous government TAMs (Golden Dome $542B / $25B initial; DARPA VLEO). The Q1 loss is dominated by non-cash Edge vesting that rolls off; underlying adjusted EBITDA is closing on breakeven (−$9.2M). The February 2026 refinance pushed the debt wall to 2029 and cut the rate (SOFR+3.25-3.75% vs the prior 13.31%). If Edge scales and Space stops bleeding EACs, this is a $700M+ revenue, EBITDA-positive defense-space platform inside three years — and at ~5x forward sales it's cheaper than RKLB/LUNR.
Bear case (2–3 permanent-impairment risks). (1) The cap table is the business. AEI controls ~48.7% and the board, bought you a related-party asset with your own diluted stock + a 15% affiliate note, and can force a sale; minority common is structurally subordinated, and the $500M ATM means the share count keeps grinding higher exactly when the price is weak — a self-reinforcing dilution spiral that has already produced ~100% dilution in a year. (2) Space is structurally low-margin and EAC-fragile — serial unfavorable cost-to-complete adjustments and a full Space-Europe goodwill write-off say the legacy core can't reliably earn a margin; $721M of fresh Edge goodwill is the next impairment if defense growth slips. (3) Cash burn + thin liquidity — −$177M operating cash FY25, only ~$94.5M cash; the company needs the equity market open to fund itself, which caps the multiple and makes it hostage to sentiment. Pre-mortem (18 months out, thesis broke): the Ukraine Penguin channel faded with a ceasefire, two more EAC overruns hit Space, adjusted EBITDA stayed negative, the ATM kept printing shares into a falling price, goodwill took a write-down, and RDW round-trips to single digits — a SpaceX-IPO-mania round-trip plus an integration that never reached operating leverage. Are multiples too high? At ~5x forward sales for a loss-maker they're not egregious vs peers, but they're entirely faith-in-the-inflection; any guidance miss re-rates hard.
Contrarian view (what the market refuses to see): the bears are fixated on dilution and the bulls on Golden Dome, but the actual swing variable is whether Space stops destroying margin. Defense Tech (Edge) is the good business hiding inside ugly purchase-accounting; legacy Space is the value-trap inside a "space stock." The market prices RDW as one thing; it is two businesses with opposite trajectories.
Lens 13 · Devil's Advocate (short-seller)
Dismantling the bull case. How the money machine breaks: Redwire only works if it can (a) keep tapping equity markets to fund burn and (b) convert backlog at a real margin. Both are fragile. Revenue concentration: top-two customers ~39%; a large slice of Defense Tech is Ukraine Penguin demand that ends with the war, and US programs (PMA-263, Golden Dome) are appropriations-and-shutdown-exposed (the 2025 shutdown already pushed orders out). Why the moat is weaker than bulls think: "combat-proven" is a credential, not a switching cost — low-cost commercial drone makers are improving fast and Anduril/AeroVironment/larger primes have vastly more capital; in Space, qualification incumbency hasn't stopped EAC overruns from erasing the margin. Most dangerous competitor bulls underestimate: Anduril (private, capital-rich, software-defined autonomy) on the Defense Tech side and the entire well-funded new-space cohort on Space. Worst capital-allocation moves: buying an AEI-affiliated company from AEI, partly with a 15-18% affiliate Seller Note, while issuing ~100% new shares — a textbook sponsor-extraction structure; plus $59M SBC in a loss-making year. Assumptions that must hold for $13: sustained ~40% growth, margin to ~24%+, EBITDA breakeven by 2027, and the ATM not crushing the price. If growth disappoints 20-30% (say FY26 lands at ~$360-380M not $475M): the EBITDA-breakeven date slips past the visible window, another raise is forced, goodwill impairment risk rises, and at ~7-8x a now-lower revenue with a worse narrative the stock has 40-60% downside to its 52-week-low zone. Single permanent-impairment scenario, plausibility: a Ukraine ceasefire + a Space goodwill write-down + a dilutive raise into weakness, stacking in the same 12 months — moderately plausible (~25-30%), and it's the scenario the bull case has no answer for.
Lens 14 · Management Questions (15, ordered by information value)
- Edge Autonomy was bought from an AEI affiliate and financed partly with a 15% affiliate Seller Note — walk us through the independent-committee process, the fairness opinion, and how the consideration was benchmarked against arm's-length comps.
- What is your dated path to positive adjusted EBITDA and to free-cash-flow breakeven, and what revenue/margin assumptions underpin it?
- How much of FY2026 Defense Tech revenue is Ukraine-dependent, and what is the order book if the war ends in the next 12 months?
- The $500M ATM: under what price/conditions will you actually issue, and how do you weigh dilution-at-weak-prices against funding burn?
- Space ran −23% operating margin on serial unfavorable EAC adjustments — what specifically has changed in contract bidding/estimation to stop the overruns, and on which programs?
- You wrote Space-Europe goodwill to zero — what is your current impairment-test headroom on the $721M of Edge goodwill, and at what growth shortfall does it impair?
- What is the organic (ex-Edge, ex-acquisition) growth and margin profile of the legacy Space business standing alone?
- With AEI at ~48.7% and a board majority plus a post-7-year forced-sale right, how should minority common holders think about your fiduciary balance and any change-of-control timeline?
- Golden Dome ($542B TAM): what is Redwire's realistic served-available share by product, and when does it convert to bookings vs press releases?
- What are the remaining Edge integration synergies and dis-synergies, quantified, and when does accelerated Edge-incentive comp fully roll off?
- R&D jumped to $12.6M in Q1 2026 from $0.8M — where is it going (SabreSat/VLEO? autonomy software?) and what's the FY run-rate?
- Customer concentration is ~39% top-two — what is the de-concentration plan and the pipeline that delivers it?
- Backlog conversion: of the $498.1M, how much converts to revenue within 12 months vs the longer tail, and how much is firm-funded vs subject to annual appropriation?
- Capital structure: with the preferred at 13-15% and mandatory-convert thresholds, what's the plan to simplify the stack (preferred, warrants, ATM) over the next 24 months?
- How do you defend the drone franchise's pricing against Anduril and low-cost commercial entrants over a 3-5 year horizon?